Literature DB >> 16629227

Good response of membranous lupus nephritis to tacrolimus.

M Maruyama1, Y Yamasaki, K Sada, A Sarai, K Ujike, Y Maeshima, Y Nakamura, H Sugiyama, H Makino.   

Abstract

A 22-year-old woman hospitalized for polyarthralgia was diagnosed with systemic lupus erythematosus (SLE). She was treated with prednisolone, and her clinical manifestations improved. However, she was re-admitted for renal biopsy because of persistent hypocomplementemia and development of proteinuria. The biopsy revealed segmental spike formation of basement membrane and subepithelial immune complex deposition, and membranous lupus nephritis (class V) was diagnosed. When tacrolimus was added to prednisolone, the serum complement titer quickly improved and proteinuria disappeared after about 11 months. Nevertheless, when tacrolimus was replaced examination showed cyclosporine due to gastrointestinal symptoms, she complained about arthralgia. Examination showed drop in the serum complement titer and recurrence of proteinuria. Renal biopsy at the time of recurrence showed increased subepithelial immune complex deposition in the capillary loops as compared to the first biopsy, a high degree of thickening of the basement membrane, and segmental circumferential interposition in some of the glomeruli. Membranous lupus nephritis (classes V + III) was diagnosed. By changing to tacrolimus and higher doses of steroids, the serum complement titer improved and proteinuria disappeared. This case indicates that tacrolimus can be an effective therapeutic agent for membranous lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16629227     DOI: 10.5414/cnp65276

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  5 in total

Review 1.  Treatment of young patients with lupus nephritis using calcineurin inhibitors.

Authors:  Hiroshi Tanaka; Kazushi Tsuruga; Tomomi Aizawa-Yashiro; Shojiro Watanabe; Tadaatsu Imaizumi
Journal:  World J Nephrol       Date:  2012-12-06

Review 2.  Revisited Cyclophosphamide in the Treatment of Lupus Nephritis.

Authors:  Xiao-Ying Quan; Hao-Tao Chen; Si-Qin Liang; Chen Yang; Cui-Wei Yao; Yong-Zhi Xu; Hua-Feng Liu; Ning An
Journal:  Biomed Res Int       Date:  2022-05-26       Impact factor: 3.246

Review 3.  Efficacy and cytokine modulating effects of tacrolimus in systemic lupus erythematosus: a review.

Authors:  Kam Hon Yoon
Journal:  J Biomed Biotechnol       Date:  2010-06-28

Review 4.  Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma.

Authors:  Chi Chiu Mok
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

5.  Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.

Authors:  Hidetoshi Kagawa; Tsutomu Hiromasa; Takayuki Hara; Ayako Takaki; Ryutaro Yamanaka; Ken-ei Sada; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2012-04-11       Impact factor: 2.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.